These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34764984)

  • 81. Ribosomal protein L22 like 1: a promising biomarker for lung adenocarcinoma.
    Wu Y; Yao N; Du B; Zhu Y; Ji X; Lv C; Lai J
    J Cancer; 2024; 15(9):2549-2560. PubMed ID: 38577587
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Bioinformatic Analysis of Prognostic Value of SNTG2 with Immune Implications in Lung Adenocarcinoma.
    Zhou J; Wen Y; Chen X; Guo L
    Int J Gen Med; 2022; 15():5181-5196. PubMed ID: 35637702
    [TBL] [Abstract][Full Text] [Related]  

  • 83. LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma.
    Jin X; Chen L; Zhou N; Ni H; Zu L; He J; Yang L; Zhu Y; Sun X; Li X; Xu S
    Front Mol Biosci; 2021; 8():711928. PubMed ID: 34901148
    [No Abstract]   [Full Text] [Related]  

  • 84. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.
    Yu L; Qiao R; Xu J; Han B; Zhong R
    Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Role of the CBX Molecular Family in Lung Adenocarcinoma Tumorigenesis and Immune Infiltration.
    Zhang C; Chang L; Yao Y; Chao C; Ge Z; Fan C; Yu H; Wang B; Yang J
    Front Genet; 2021; 12():771062. PubMed ID: 34966411
    [No Abstract]   [Full Text] [Related]  

  • 86. RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma.
    Liu B; Wang Y; Wang H; Li Z; Yang L; Yan S; Yang X; Ma Y; Gao X; Guan Y; Yi X; Xia X; Li J; Wu N
    Front Oncol; 2021; 11():677826. PubMed ID: 34367963
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma.
    Jin J; Liu C; Yu S; Cai L; Sitrakiniaina A; Gu R; Li W; Wu F; Xue X
    Aging (Albany NY); 2021 Jun; 13(12):16144-16164. PubMed ID: 34115610
    [TBL] [Abstract][Full Text] [Related]  

  • 88. FURIN correlated with immune infiltration serves as a potential biomarker in SARS-CoV-2 infection-related lung adenocarcinoma.
    Luo L; Li M; Su J; Yao X; Luo H
    Clin Exp Med; 2022 Aug; 22(3):371-384. PubMed ID: 34510311
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Comprehensive Analysis of Aquaporin Superfamily in Lung Adenocarcinoma.
    Lin G; Chen L; Lin L; Lin H; Guo Z; Xu Y; Hu C; Fu J; Lin Q; Chen W; Zeng Y; Xu Y
    Front Mol Biosci; 2021; 8():736367. PubMed ID: 34708074
    [No Abstract]   [Full Text] [Related]  

  • 90. Prognostic Value of Complement Properdin in Cancer.
    Mangogna A; Varghese PM; Agostinis C; Alrokayan SH; Khan HA; Stover CM; Belmonte B; Martorana A; Ricci G; Bulla R; Kishore U
    Front Immunol; 2020; 11():614980. PubMed ID: 33542722
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis.
    He Y; Liu R; Yang M; Bi W; Zhou L; Zhang S; Jin J; Liang X; Zhang P
    Front Oncol; 2021; 11():639600. PubMed ID: 33968738
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Bioinformatic analysis of PLOD family member expression and prognostic value in non-small cell lung cancer.
    Qi Q; Huang W; Zhang H; Zhang B; Sun X; Ma J; Zhu C; Wang C
    Transl Cancer Res; 2021 Jun; 10(6):2707-2724. PubMed ID: 35116582
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Prognostic value of tumor immune microenvironment factors in patients with stage I lung adenocarcinoma.
    Xue Q; Wang Y; Zheng Q; Chen L; Lin Y; Jin Y; Shen X; Li Y
    Am J Cancer Res; 2023; 13(3):950-963. PubMed ID: 37034213
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Ferroptosis regulator FANCD2 is associated with immune infiltration and predicts worse prognosis in lung adenocarcinoma.
    Ye C; Lu Y; Yuan Z; Mi M; Qi L; Yuan Y; Weng S
    Front Genet; 2022; 13():922914. PubMed ID: 36267413
    [TBL] [Abstract][Full Text] [Related]  

  • 96. GBE1 Is an Independent Prognostic Marker and Associated With CD163
    Liang Y; Lei Y; Liang M; Du M; Liu Z; Li X; Meng X; Zhou B; Gao Y
    Front Oncol; 2021; 11():781344. PubMed ID: 35155189
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Clinical Prognostic Value of the
    Meng Y; Sun J; Zhang G; Yu T; Piao H
    Front Mol Biosci; 2021; 8():770729. PubMed ID: 35265665
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Inducible Co-Stimulator ICOS Expression Correlates with Immune Cell Infiltration and Can Predict Prognosis in Lung Adenocarcinoma.
    Wu G; He M; Ren K; Ma H; Xue Q
    Int J Gen Med; 2022; 15():3739-3751. PubMed ID: 35418779
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prognostic Implications and Immune Infiltration Characteristics of Chromosomal Instability-Related Dysregulated CeRNA in Lung Adenocarcinoma.
    Guo S; Li T; Xu D; Xu J; Wang H; Li J; Bi X; Cao M; Xu Z; Xia Q; Cui Y; Li K
    Front Mol Biosci; 2022; 9():843640. PubMed ID: 35419410
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma.
    Wang G; Zhong Y; Liang J; Li Z; Ye Y
    PeerJ; 2020; 8():e8625. PubMed ID: 32117639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.